drugset / Trial / NCT02916602

A Study to Evaluate Efficacy and Safety of HCP1401 for Stage 2 Hypertension Patients Not Controlled by HCP0605

NCT02916602

Phase 3 Completed 340 enrolled Hanmi Pharmaceutical Company Limited
RandomizedParallel-groupDouble-blindTreatment

Summary

A phase 3 study to evaluate efficacy and safety of HCP1401

Timeline

Start
2015-04
Primary completion
2016-09
Completion
2016-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Chlorthalidone Other / unclassified
Background Amlodipine Other / unclassified
Background Losartan Other / unclassified

Indications